Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin
Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin
About this item
Full title
Author / Creator
Váradi, Judit , Hermenean, Anca , Gesztelyi, Rudolf , Jeney, Viktória , Balogh, Enikő , Majoros, László , Malanga, Milo , Fenyvesi, Éva , Szente, Lajos , Bácskay, Ildikó , Vecsernyés, Miklós , Fehér, Pálma , Ujhelyi, Zoltán , Vasvári, Gábor , Árvai, István , Rusznyák, Ágnes , Balta, Cornel , Herman, Hildegard and Fenyvesi, Ferenc
Publisher
Switzerland: MDPI
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI
Subjects
More information
Scope and Contents
Contents
2-Hydroxypropyl-beta-cyclodextrin (HPBCD) is utilized in the formulation of pharmaceutical products and recently orphan designation was granted for the treatment of Niemann-Pick disease, type C. The exact mechanism of HPBCD action and side effects are not completely explained. We used fluorescently labelled hydroxypropyl-beta-cyclodextrin (FITC-HPB...
Alternative Titles
Full title
Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5febeb5218514b2e879d0cc534698198
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5febeb5218514b2e879d0cc534698198
Other Identifiers
ISSN
2218-273X
E-ISSN
2218-273X
DOI
10.3390/biom9100509
